What is Semaglutide?
Semaglutide is a glucagon-like peptide (GLP-1) analog approved in 2017 as a treatment method for improving glycemic control in patients with Type 2 diabetes. Semaglutide shows great promise for patients who are having difficulty losing weight.
Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control. The greatest weight loss benefits were observed when Semaglutide is used in combination with lifestyle changes, such as improved diet and consistent exercise.
How does Semaglutide work?
GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, lowering blood sugar.
Semaglutide has demonstrated beneficial effects on glycemia and a host of other benefits.
Reported Benefits:
• Weight Loss
• Neuroprotective
• Smoking Cessation
• Cardiovascular Benefits
Side effects/contraindications:
The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, and constipation. The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions.
This medication is not an insulin and should not be used if:
• You have type 1 diabetes or if you develop diabetic ketoacidosis.